Sharat Singh
Technik-/Wissenschafts-/F&E-Leiter bei PROSPECT RESOURCES LIMITED
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Eric d'Esparbes | M | 56 | 5 Jahre | |
Jeffrey Alter | M | 61 | 5 Jahre | |
Clarke Neumann | M | 60 | 10 Jahre | |
Mark Wheatley | M | 62 | 3 Jahre | |
Ian John Goldberg | M | - | 3 Jahre | |
Jill Howe | F | 48 | 3 Jahre | |
Adi Mohanty | M | 57 | 3 Jahre | |
Lynne Powell | F | 57 | 5 Jahre | |
Jeffrey Allen Ferrell | M | 49 | 10 Jahre | |
Brian Kotzin | M | 74 | 5 Jahre | |
Samuel Hosack | M | - | 6 Jahre | |
Robyn Hatton | F | - | 11 Jahre | |
Ariella Kelman | M | - | 1 Jahre | |
John Maketo | M | - | 5 Jahre | |
Michael Rhode | M | - | - | |
Allison Luo | M | 50 | 7 Jahre | |
Roger Tyler | M | - | 11 Jahre | |
Guarav Gupta | M | - | 1 Jahre | |
Harry Miller | M | - | 1 Jahre | |
David Broomfield | M | - | 2 Jahre | |
Zivanayi L. Rusike | M | 65 | 11 Jahre | |
Gerry Fahey | M | 71 | 11 Jahre | |
Paul W. Shabram | M | - | 2 Jahre | |
James Winch | M | - | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Herb H. Hooper | M | 60 |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | - |
Alfred G. Merriweather | M | 70 |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | 3 Jahre |
Tom Baruch | M | 85 |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | - |
Thomas G. Klopack | M | - |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | - |
John Mendlein | M | 64 |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | 1 Jahre |
André F. Marion | M | 88 |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | - |
Stephen C. Macevicz | M | - |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | - |
Kevin Tang | M | 57 |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | - |
Michael Dunn | M | 68 |
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | 1 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 22 | 66,67% |
Australien | 11 | 33,33% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Sharat Singh
- Persönliches Netzwerk